Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Cutan Med Surg ; 23(6): 624-634, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31253050

RESUMO

Genital ulcer disease can be caused by a wide variety of sources. Most commonly, genital ulcer disease is grouped into infectious and noninfectious causes. HSV, syphilis, lymphogranuloma venereum, and chancroid represent some common infectious ulcers. Noninfectious causes on the other hand can be inflammatory, noninflammatory, or malignant (eg, squamous cell carcinoma). Depending on the etiology, genital ulcers may present with unique features that can help clinicians identify the etiology and start treatment in a timely manner. The clinical presentation and management of infectious and noninfectious genital ulcers will be discussed in this review.


Assuntos
Doenças dos Genitais Femininos , Doenças dos Genitais Masculinos , Úlcera , Síndrome de Behçet , Doença de Crohn , Feminino , Humanos , Masculino , Pioderma Gangrenoso , Infecções Sexualmente Transmissíveis
3.
J Cutan Med Surg ; 19(2): 159-62, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25775625

RESUMO

BACKGROUND/OBJECTIVES: The clinical and histopathologic findings of a rare simultaneous occurrence of papulonecrotic tuberculid and nodular tuberclid in a patient with active but asymptomatic pulmonary tuberculosis are presented. Papulonecrotic tuberculid was observed at a very early stage, presenting as molluscum-like lesions. This has been described once in the literature. This was observed in conjunction with lesions compatible with the rare clinicopathologic variant of nodular tuberculid. Critical to the diagnosis of active pulmonary tuberculosis was the use of induced sputum testing, which confirmed the diagnosis despite the lack of a cough and a chest x-ray negative for active tuberculosis. METHODS/RESULTS: A 40-year-old male presented with a 2-week history of fever and a skin eruption consisting of molluscum-like papules on the ears, arms, and abdomen and nodules on his legs. Biopsies from both lesions were consistent with papulonecrotic and nodular tuberculid, respectively. Despite the lack of any respiratory symptoms, induced sputum grew Mycobacterium tuberculosis, and the lesions resolved on antituberculous therapy. CONCLUSIONS AND RELEVANCE: Tuberculids are rare in Western countries but must be considered in the differential diagnosis of eruptions in patients from endemic countries. An active tuberculous focus must be sought out.


Assuntos
Pele/patologia , Tuberculose Cutânea/diagnóstico , Tuberculose Pulmonar/diagnóstico , Adulto , Biópsia , Diagnóstico Diferencial , Humanos , Masculino , Mycobacterium tuberculosis/isolamento & purificação , Pele/microbiologia , Tuberculose Cutânea/complicações , Tuberculose Pulmonar/complicações
4.
J Cutan Med Surg ; 18(4): 243-55, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25008441

RESUMO

BACKGROUND: Most treatment guidelines for acne are based on clinical severity. Our objective was to expand that approach to one that also comprised individualized patient features: a case-based approach. METHODS: An expert panel of Canadian dermatologists was established to develop demographic and clinical features considered to be particularly important in acne treatment selection. A nominal group consensus process was used for inclusion of features and corresponding appropriate treatments. RESULTS: Consensus was achieved on the following statements: follicular epithelial dysfunction contributes to acne pathogenesis; inflammation from underlying disease(s) or prior treatment may impact further patient management; management focusing on specific patient features and on addressing psychosocial factors, including impact on quality of life, may improve treatment adherence and outcomes; and case-based scenarios are a practical approach to illustrate the effect of these factors. To address the latter, eight case profiles were developed. CONCLUSIONS: Management of acne should be based on multifactorial considerations beyond clinically determined acne severity and should include patient-reported impact, gender, skin sensitivity (including preexisting dermatoses), and phototype.


Assuntos
Acne Vulgar/terapia , Gerenciamento Clínico , Seleção de Pacientes , Complicações na Gravidez/terapia , Acne Vulgar/patologia , Acne Vulgar/psicologia , Adolescente , Adulto , Fatores Etários , Canadá , Consenso , Fármacos Dermatológicos/uso terapêutico , Feminino , Humanos , Masculino , Gravidez , Complicações na Gravidez/patologia , Complicações na Gravidez/psicologia , Qualidade de Vida , Fatores Sexuais , Resultado do Tratamento , Adulto Jovem
5.
Skin Therapy Lett ; 15(10): 5-7, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21076800

RESUMO

Benzoyl peroxide is one of the most widely used topical agents for acne. It has potent antibacterial and mild anti-inflammatory and comedolytic effects. To treat mild to moderate acne, it can be used alone or in combination with topical antibiotics and topical retinoids. The combination of benzoyl peroxide with either erythromycin or clindamycin is synergistic and well-tolerated. In more severe acne, when oral antibiotics are required, benzoyl peroxide can contribute to suppressing the emergence of resistant strains of Propionibacterium acnes.


Assuntos
Acne Vulgar/tratamento farmacológico , Antibacterianos/uso terapêutico , Peróxido de Benzoíla/uso terapêutico , Acne Vulgar/microbiologia , Administração Cutânea , Antibacterianos/administração & dosagem , Antibacterianos/efeitos adversos , Peróxido de Benzoíla/administração & dosagem , Peróxido de Benzoíla/efeitos adversos , Clindamicina/administração & dosagem , Clindamicina/efeitos adversos , Clindamicina/uso terapêutico , Fármacos Dermatológicos/administração & dosagem , Fármacos Dermatológicos/efeitos adversos , Fármacos Dermatológicos/uso terapêutico , Farmacorresistência Bacteriana , Sinergismo Farmacológico , Quimioterapia Combinada , Eritromicina/administração & dosagem , Eritromicina/efeitos adversos , Eritromicina/uso terapêutico , Humanos , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...